Events - ISN-ASON Webinar: Management of anemia in cancer patients and VEGF inhibitors related kidney adverse events

This webinar will explore key recommendations from the latest American Society of Onco-Nephrology (ASON) position statements, focusing on two important areas at the intersection of oncology and kidney care: the management of anemia in patients with cancer and kidney-related adverse events associated with vascular endothelial growth factor (VEGF) inhibitors. Expert speakers will discuss practical approaches to evaluating and managing anemia in the complex setting of cancer and kidney disease, as well as the recognition, assessment, and management of kidney complications related to VEGF-targeted therapies. Through a clinically focused discussion, the session will highlight how current recommendations can inform multidisciplinary decision-making and support safe, effective cancer treatment while protecting kidney health.

Learning objectives:

• Discuss current recommendations for the evaluation and management of anemia in patients with cancer, including important considerations for patients with impaired kidney function.
• Recognize and assess kidney-related adverse events associated with VEGF inhibitors, including hypertension, proteinuria, and kidney dysfunction.
• Apply the latest ASON position statement recommendations to clinical practice, supporting multidisciplinary decision-making and balancing effective cancer therapy with the prevention and management of kidney complications.